Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
---|
02/25/2010 | US20100047187 Methods of treating parkinson's disease using halogenated volatile compounds |
02/25/2010 | US20100043788 Devices and methods for minimizing and treating high-altitude sickness |
02/25/2010 | CA2734788A1 Systems and devices for generating nitric oxide |
02/24/2010 | EP2156820A1 Skin whitening agent |
02/24/2010 | EP2155215A1 A gold nanoparticle based protease imaging probes and use thereof |
02/24/2010 | EP2155214A1 Method for pain control |
02/24/2010 | EP2154961A1 Anti-microbial composition and method for making and using same |
02/24/2010 | EP1869185B1 Conjugate comprising p21 protein for the treatment of cancer |
02/24/2010 | EP1689381B1 Pharmaceutical composition comprising i.a. vitamin c, magnesium, green tea extract for retarding cardiovascular diseases (smc proliferation) |
02/24/2010 | EP1294422B1 Medical System for Reducing Vascular Occlusions |
02/24/2010 | CN201409610Y Medicine toothbrush |
02/24/2010 | CN101657205A Agent for preventing bleeding from cerebral cortical vein |
02/24/2010 | CN101653458A Microelement composition for improving reproduction performance of breeding pigs |
02/24/2010 | CN101653457A Microelement composition for promoting growth of suckling pigs |
02/24/2010 | CN101653456A Microelement composition for promoting growth of growing-finishing pigs |
02/24/2010 | CN101653455A Microelement composition for improving production performance of layer chicken |
02/24/2010 | CN101653454A Medicament capable of dehydrating and withering pathological tissues |
02/24/2010 | CN101653453A New application of montmorillonite |
02/24/2010 | CN101653452A Vermiculite extracting solution and application thereof |
02/24/2010 | CN100591331C Combination chemotherapy compositions |
02/23/2010 | US7666829 Compositions for elastogenesis and connective tissue treatment |
02/23/2010 | US7666638 Preparing selenium-enriched biomass having Se-methionine content of at least 11.39 ng/mgd.w. by culturing microorganisms selected from Lactobacillus reuteri DSM16143, Lactobacillus ferintoshensis DSM16144 and Lactobacillus buchneri/parabuchneri DSM16341 in culture medium comprising selenium salt |
02/23/2010 | US7666453 Mineral oil, zinc oxide, gum karaya powder, tea tree oil, aloe vera and a fungicide amphotericin B, butoconazole, clotrimazole, fluconazole, miconazole, ketoconazole, flucytosine, terbinafine, itraconazole, and terconazole; diaper rash; psoriasis, eczema, ichthyosis, pruritus, dryness, dermatitis |
02/18/2010 | WO2010019164A1 Optical blurring pigment composition suitable for use in cosmetics |
02/18/2010 | WO2010018418A1 Formulation based on micronized clinoptilolite as therapeutic agent providing highly bioavailable silicon |
02/18/2010 | WO2010018278A2 Composition comprising crystallisation inhibitory substances |
02/18/2010 | WO2010017633A1 Use of nitric oxide |
02/18/2010 | WO2010017623A1 Antimicrobial silver solutions |
02/18/2010 | WO2009154819A3 Treatment of inflammatory conditions and diseases with metal-thiols |
02/18/2010 | WO2009140341A3 Atorvastatin compositions |
02/18/2010 | WO2009139972A3 Site specific fluorescence marking and contrast marker for same |
02/18/2010 | WO2009120697A3 Method and compositions for treatment of cancer |
02/18/2010 | WO2008121006A8 Selenium administration |
02/18/2010 | US20100040703 Use of nitric oxide |
02/18/2010 | US20100040700 Kit for promoting hair growth |
02/18/2010 | US20100040686 Biomaterial |
02/18/2010 | US20100040628 Indoprofen derivatives for promoting bone growth |
02/18/2010 | US20100040603 Methods for promoting protection and regeneration of bone marrow using cxcl9 and anti-cxcl9 antibodies |
02/18/2010 | US20100040599 Therapeutic agent for rheumatoid arthritis |
02/18/2010 | US20100040565 Active delivery systems formulations |
02/18/2010 | CA2733509A1 Antimicrobial silver solutions |
02/18/2010 | CA2732881A1 Composition that comprises crystallisation inhibitory substances |
02/18/2010 | CA2709097A1 Optical blurring pigment composition suitable for use in cosmetics |
02/17/2010 | EP2152321A1 Water treatment containing dbnpa for use in sanitizing recreational water |
02/17/2010 | EP2152278A2 Enhancement of the calcium sensing receptor |
02/17/2010 | EP2152239A1 Stable oxaliplatin composition for parenteral administration |
02/17/2010 | CN101647810A Liquid calcium soft capsule |
02/17/2010 | CN101647809A Traditional Chinese medicine powder for treating toothache due to fire-evil |
02/16/2010 | US7662373 Comprising an emulsifier, a bowel relaxant and one or more chelating agents to absorb and mechanically agitate non-digested fats; decreased side effects |
02/16/2010 | US7661424 Method of use of gas mixtures to achieve nitrogen washout from the body and mitochondria of the heart |
02/16/2010 | CA2430001C Light stabilized antimicrobial materials |
02/16/2010 | CA2421721C Therapeutic topical solution for skin and associated methods of use |
02/11/2010 | WO2010017443A2 Anti-beta-2-microglobulin agents and the use thereof |
02/11/2010 | WO2010016581A1 Ultrasonic cancer therapy accelerator |
02/11/2010 | WO2010015697A1 Anti-allergen combinations of calcium and lanthanum salts |
02/11/2010 | US20100034902 Method for the diagnosis and treatment of salt sensitivity and related conditions |
02/11/2010 | US20100034901 Animal feed compositions |
02/11/2010 | US20100034899 Use of one or more of the elements from the group yttrium, neodymium and zirconium, and pharmaceutical compositions which contain those elements |
02/11/2010 | US20100034898 Cartilage simulating bio-material composition and method |
02/11/2010 | US20100034893 Particulate uv protection agent |
02/11/2010 | US20100034882 Silver-containing compositions, devices and methods for making |
02/11/2010 | US20100034874 Liposome encapsulating ammine-platinum complex at high concentration, and method for production of the liposome |
02/11/2010 | US20100034873 Transdermal ricinoleic acid compositions |
02/11/2010 | US20100034865 Osteoinductive calcium phosphates |
02/11/2010 | US20100034813 Substituted pyrazole and triazole compounds as ksp inhibitors |
02/11/2010 | CA2730778A1 Anti-allergen combinations of calcium and lanthanum salts |
02/10/2010 | EP2151242A1 Use of oxygen for treatment of illnesses of the mucous membrane of the intestinal channel |
02/10/2010 | EP1499331B1 Salt solution for colon cleansing |
02/10/2010 | CN101642468A Pharmaceutical composition for lowering blood glucose and blood lipids |
02/10/2010 | CN100588406C Medicament for treating chronic renal failure and production method |
02/09/2010 | USRE41109 Includes sulfuric acid combined with distilled water and ammonium sulfate under at least 15 psi pressure in a pressurized container, heated to approximately 800 degrees F. or more for at least 3 hours, stabilized with 10 percent of original mixture; for preserving food, and for treatment of melanoma |
02/09/2010 | US7659257 Medicament for treating lung cancer |
02/09/2010 | US7658952 Dialysis solutions containing pyrophosphates |
02/09/2010 | US7658940 Mixing kit components containing a setting fluid, dry calcium carbonate, oxide or hydroxide, dry phosphoric acid and bone particles, making a flowable, moldable mixture for orthopedics or dentistry |
02/09/2010 | US7658914 first container containing a dry formulation of polyoxyethylene glycol , ascorbic acid and sodium sulfate, calcium sulfate and sodium chloride, potassium chloride, second container containing dry ascorbic acid or sodium or potassium salt; also contains flavor, sweetener; for colonoscopy preperation |
02/09/2010 | CA2407112C Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents |
02/09/2010 | CA2286614C Plant extracts for the treatment of increased bone resorption |
02/04/2010 | WO2010014818A1 Methods of treating an infection with nitric oxide |
02/04/2010 | WO2010013785A1 Adsorbent, cleansing agent, remedy for kidney disease and functional food |
02/04/2010 | WO2010013129A1 Coccidiocide combination for veterinary use |
02/04/2010 | WO2010012720A1 Compositions for the prophylaxis and treatment of dermatological/mucosal diseases, and uses thereof |
02/04/2010 | WO2009151496A9 Induction of proliferation, effector molecule expression, and cytolytic capacity of hiv-specific cd8+ t cells |
02/04/2010 | WO2009129208A3 Compositions and methods of inducing endoplasmic reticulum stress reponse |
02/04/2010 | US20100028461 Gamma-butyrolactone compound and pharmaceutical composition thereof |
02/04/2010 | US20100028460 Improvements in relation to cancer therapy |
02/04/2010 | US20100028459 Nutritional supplement composition for treatment of ocular diseases |
02/04/2010 | US20100028458 Mild composition for skin disinfection |
02/04/2010 | US20100028457 Agent for prevention or treatment of blood glucose level elevation |
02/04/2010 | US20100028456 Broad-spectrum antiviral composition with excellent preservation stabilty |
02/04/2010 | US20100028443 Compositions and methods for treating inflammation |
02/04/2010 | US20100028441 Compositions and methods for treating multiple sclerosis |
02/04/2010 | US20100028436 Polymer matrix, uses thereof and a method of manufacturing the same |
02/04/2010 | US20100028413 Skin treatment strip |
02/04/2010 | US20100028395 Compositions containing n-acetylglucosamine for use in dermo-cosmetology and aesthetic medicine |
02/04/2010 | US20100028338 Gimatecan (7-t-butoxyiminomethylcamptothecin) and chemotherapeutic agents |
02/04/2010 | US20100028318 Agent for relief or prevention of xerostomia |
02/04/2010 | DE20321786U1 Kombinationspräparat aus oralem Kontrazeptivum und Calcium/Vitamin D Combination preparation of oral contraceptive and calcium / vitamin D |
02/04/2010 | CA2732340A1 Compositions for the prophylaxis and treatment of dermatological/mucosal diseases, and uses thereof |
02/03/2010 | EP2149376A1 Body-temperature lowering depressant |
02/03/2010 | EP2149375A1 Compositions for the treatment of dermatological diseases, and uses thereof |